BindingDB

The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.1M data for 1.4M Compounds and 9.6K Targets. Of those, 1.5M data for 718K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Donate Now

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

Advanced Search

8 articles for thisTarget

The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Discovery of 1,5-benzodiazepines with peripheral cholecystokinin (CCK-A) receptor agonist activity. 1. Optimization of the agonist"trigger".EBI
Glaxo Wellcome
Solid-phase/solution-phase combinatorial synthesis of neuroimmunophilin ligands.EBI
Glaxo Wellcome
Structure-activity relationships of a series of substituted benzamides: potent D2/5-HT2 antagonists and 5-HT1a agonists as neuroleptic agents.EBI
Glaxo Wellcome
The discovery of potent cRaf1 kinase inhibitors.EBI
Glaxo Wellcome
Binding mode of the 4-anilinoquinazoline class of protein kinase inhibitor: X-ray crystallographic studies of 4-anilinoquinazolines bound to cyclin-dependent kinase 2 and p38 kinase.EBI
Glaxo Wellcome
Synthesis and evaluation of heterocyclic carboxamides as potential antipsychotic agents.EBI
Glaxo Wellcome
Effect of linking bridge modifications on the antipsychotic profile of some phthalimide and isoindolinone derivatives.EBI
Glaxo Wellcome
Substituted indole-2-carboxylates as in vivo potent antagonists acting as the strychnine-insensitive glycine binding site.EBI
Glaxo Wellcome